NCT03142139 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Aaby P, Kollmann TR, Benn CS
Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges. Nat Immunol. 2014 Oct;15(10):895-9. doi: 10.1038/ni.2961.
Kildemoes HW, Sørensen HT, Hallas J
The Danish National Prescription Registry. Scand J Public Health. 2011 Jul;39(7 Suppl):38-41. doi: 10.1177/1403494810394717.
Kiraly N, Koplin JJ, Crawford NW, Bannister S, Flanagan KL, Holt PG, Gurrin LC, Lowe AJ, Tang ML, Wake M, Ponsonby AL, Dharmage SC, Allen KJ
Timing of routine infant vaccinations and risk of food allergy and eczema at one year of age. Allergy. 2016 Apr;71(4):541-9. doi: 10.1111/all.12830. Epub 2016 Feb 8.
Larsson M, Hägerhed-Engman L, Sigsgaard T, Janson S, Sundell J, Bornehag CG
Incidence rates of asthma, rhinitis and eczema symptoms and influential factors in young children in Sweden. Acta Paediatr. 2008 Sep;97(9):1210-5. doi: 10.1111/j.1651-2227.2008.00910.x.
Lynge E, Sandegaard JL, Rebolj M
The Danish National Patient Register. Scand J Public Health. 2011 Jul;39(7 Suppl):30-3. doi: 10.1177/1403494811401482.
Nilsson L, Grüber C, Granström M, Björkstén B, Kjellman NI
Pertussis IgE and atopic disease. Allergy. 1998 Dec;53(12):1195-201.
Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT
The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015 Nov 17;7:449-90. doi: 10.2147/CLEP.S91125. eCollection 2015. Review.
Sørup S, Benn CS, Poulsen A, Krause TG, Aaby P, Ravn H
Live vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections. JAMA. 2014 Feb 26;311(8):826-35. doi: 10.1001/jama.2014.470.

Timing of Vaccination With the Non-live DTaP-IPV-Hib Vaccine and Development of Atopic Dermatitis Before 1 Year of Age - a Danish Register Based Cohort Study

Details for clinical trial NCT03142139

Clinical trial NCT03142139 - References